Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EyePoint Pharmaceuticals, Inc. | Director | Common Stock | 1.85K | $18.6K | $10.06 | Jul 12, 2024 | Direct |
EyePoint Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 6.53K | Jul 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals, Inc. | Jul 12, 2024 | 5 | -$84.3K | 4 | Jul 16, 2024 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 3, 2024 | 5 | -$87.1K | 4 | Jun 4, 2024 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | May 14, 2024 | 5 | -$114K | 4 | May 16, 2024 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Jan 5, 2024 | 1 | $0 | 4 | Jan 9, 2024 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 20, 2023 | 2 | $0 | 4 | Jun 22, 2023 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2023 | 2 | $0 | 4 | Feb 13, 2023 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2022 | 4 | $0 | 4 | Feb 11, 2022 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 22, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Director |